AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2010
Dec 13, 2010
33390_dirs_2010-12-13_ff4450d3-2a70-4ff5-85f0-18b16ee071b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2010-12-13
Reporting Person: Kelly James Patrick (SVP, CFO, Treasurer & Secretar)
More from Vanda Pharmaceuticals Inc.
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19